| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.27 | 2e-07 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-06 |